Clin2
NCT07534475Likely a fitRecruiting

Tourniquet Type for Monitoring Brain Activity During ECT

Major Depressive DisorderBipolar DisorderSchizophrenia

Treatments studied

Part of Mental health clinical trials.

This study compares two types of arm tourniquets (blood-pressure cuffs) used during electroconvulsive therapy (ECT) to help doctors monitor seizure activity more accurately. ECT is a treatment for severe depression and other psychiatric conditions, and tourniquets help track how well the treatment is working.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
20 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are scheduled to have electroconvulsive therapy (ECT) as an elective procedure
  • Your overall health status allows you to safely undergo anesthesia (ASA class I, II, or III)
  • You do not have neuromuscular diseases like Myasthenia Gravis
  • You are not allergic to common anesthesia medications (sugammadex, rocuronium, ketamine, dexmedetomidine, or propofol)
  • You do not have vein problems, lymphedema, or active infection in your arms
  • Your heart is stable enough to tolerate the procedure

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07473648Recruiting
A trial of ECT and magnetic seizure therapy for mood disorders

This study compares two types of brain stimulation treatments—electroconvulsive therapy (ECT) and magnetic seizure therapy (MST)—to see which works better for people with certain mental health conditions. It may be an option if you have a mood disorder or vision problems that could be helped by these treatments.

Hefei, Anhui
NCT06529029Recruiting· Phase 2/Phase 3
Comparing new low-pulse ECT to standard ECT for depression

This trial tests a new type of seizure therapy (low amplitude pulse seizure therapy) against the standard ultra-brief right unilateral ECT for people with severe depression, including those with suicidal thoughts. The goal is to see which treatment works better.

Grand Rapids, Michigan
NCT07088380Recruiting· Phase 3
Ketamine combined with ECT for hard-to-treat depression

This trial tests whether adding ketamine to electroconvulsive therapy (ECT) works better than ECT alone for people with depression that hasn't improved with at least two different antidepressants. It may offer a new option for those who have not found relief from standard treatments.

Milan
NCT07748091Recruiting
Brain wave and inflammation markers in shock therapy for depression

This study looks at brain wave patterns and markers of inflammation in people with depression that hasn't improved with other treatments and who are receiving electroconvulsive therapy (ECT, also known as shock therapy). The goal is to understand how these markers might relate to how well ECT works.

Istanbul, Bakırköy
NCT07740694Recruiting
ECT study for older adults with depression

This study looks at how ECT affects brain activity and inflammation in older adults with depression. It may help researchers understand why ECT works and improve treatment.

Istanbul, Bakırköy
NCT07561307Not yet recruiting
Improving electroconvulsive therapy settings and monitoring

This study helps doctors find the best settings for electroconvulsive therapy (ECT), a treatment for severe depression and other mental health conditions. Researchers will use special monitoring equipment to measure brain activity during your ECT sessions to improve how the treatment works.

Philadelphia, Pennsylvania

Hear when a new Major Depressive Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.